WHO downgrades status of oseltamivir

BMJ (Online)

Volumn 358, Issue , 2017, Pages

  Ebell, Mark H ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; ANTIVIRUS AGENT;

DRUG APPROVAL; DRUG CONTROL; DRUG COST; DRUG INDUSTRY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HUMAN; INFLUENZA; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); WORLD HEALTH ORGANIZATION; HEALTH CARE PLANNING; MORTALITY; OBSERVATIONAL STUDY;

ANTIVIRAL AGENTS; HUMANS; INFLUENZA, HUMAN; OBSERVATIONAL STUDIES AS TOPIC; OSELTAMIVIR; STRATEGIC STOCKPILE; WORLD HEALTH ORGANIZATION;

EID: 85024092063     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.j3266     Document Type: Editorial

References (18)

1. Roche receives FDA approval of Tamiflu, first pill to treat the most common strains of influenza. Press release, October 1999. http://www.gilead.com/news/press-releases/1999/ 10/roche-receives-fda-approval-of-tamiflu-first-pill-to-treat-the-most-common-strains-ofinfluenza-ab.
2. European Medicines Agency. Tamiflu.http://www.ema.europa.eu/ema/index.jsp curl=pages/medicines/human/medicines/000402/human-med-001075.jsp& mid=WC0b01ac058001d124.
3. Abbasi K. The missing data that cost $20bn. BMJ 2014;358:g2695doi:10.1136/bmj.g2695.
4. World Health Organization. WHO model list of essential medicines. 16th list (updated). 2010. http://apps.who.int/iris/bitstream/10665/70643/1/a95060-eng.pdf.
5. Jack A. Tamiflu: "a nice little earner."BMJ 2014;358:g2524. doi:10.1136/bmj.g2524 pmid: 24811410.
6. CDC. Update on flu season 2014-15. Press briefing, 9 Jan 2014. https://www.cdc.gov/ media/releases/2015/t0108-flu-update.html
7. Jefferson T, Doshi P. Multisystem failure: the story of anti-influenza drugs. BMJ 2014;358:g2263. doi:10.1136/bmj.g2263 pmid:24721793.
8. Nicholson KG, Aoki FY, Osterhaus ADME, et al. Neuraminidase Inhibitor Flu Treatment Investigator Group. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Lancet 2000;358:1845-50. doi:10.1016/S0140-6736(00)02288-1 pmid:10866439.
9. Treanor JJ, Hayden FG, Vrooman PS, et al. US Oral Neuraminidase Study Group. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. JAMA 2000;358:1016-24. doi:10.1001/jama.283.8.1016 pmid: 10697061.
10. Kashiwagi S, Kudoh S, Watanabe A, Yoshimura I. [Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza-placebo-controlled double-blind multicenter phase III trial]Article in Japanese.Kansenshogaku Zasshi 2000;358:1044-61. doi:10.11150/ kansenshogakuzasshi1970.74.1044 pmid:11193557.
11. Hurt AC, Alexander R, Hibbert J, Deed N, Barr IG. Performance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol 2007;358:132-5. doi: 10.1016/j.jcv.2007.03.002 pmid:17452000.
12. Howick J, Cals JW, Jones C, et al. Current and future use of point-of-care tests in primary care: an international survey in Australia, Belgium, The Netherlands, the UK and the USA. BMJ Open 2014;358:e005611. doi:10.1136/bmjopen-2014-005611 pmid:25107438.
13. Jefferson T, Jones M, Doshi P, Del Mar C. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ 2009;358:b5106. doi:10.1136/bmj.b5106 pmid:19995812.
14. Doshi P. Neuraminidase inhibitors-the story behind the Cochrane review. BMJ 2009;358:b5164. doi:10.1136/bmj.b5164 pmid:19995813.
15. Ebell MH, Call M, Shinholser J. Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials. Fam Pract 2013;358:125-33. doi:10.1093/fampra/ cms059 pmid:22997224.
16. Jefferson T, Jones M, Doshi P, Spencer EA, Onakpoya I, Heneghan CJ. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ 2014;358:g2545. doi:10.1136/bmj.g2545 pmid:24811411.
17. Freemantle N, Calvert M. What can we learn from observational studies of oseltamivir to treat influenza in healthy adultsBMJ 2009;358:b5248. doi:10.1136/bmj.b5248 pmid: 19995814.
18. US Food and Drug Administration. The FDA approves first generic version of widely used influenza drug, Tamiflu. https://www.fda.gov/drugs/drugsafety/ postmarketdrugsafetyinformationforpatientsandproviders/ucm514854.htm.